Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial

BY news

The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period.
source
Sponsor:News technical sponsor
Sponsor:News AI sponsor
Sponsor: AI sponsor
Sponsor: AI sponsor

Leave a Comment

Vélemény, hozzászólás?

Az e-mail címet nem tesszük közzé. A kötelező mezőket * karakterrel jelöltük

Related Posts

BusinessITNewsPopularTrends

Britain considers tougher internet safety laws after riots, Musk comments — what you need to know

The U.K. is considering ways to toughen up internet safety regulations after far-right riots sparked by misinformation and incendiary comments from Elon Musk.sourceSponsor:News technical sponsor Spons

BusinessITNewsPopularTrends

Microsoft hires former GE CFO Carolina Dybeck Happe as new operating chief

Carolina Dybeck Happe is joining Microsoft’s top leadership ranks after helping GE to bring its aviation and energy businesses public.sourceSponsor:News technical sponsor Sponsor:News AI sponsor

Business

Kohl's bets on Babies R Us as it tries to attract younger families, higher sales

Kohl’s wants to cater more to young families and give them another reason to visit its stores through the Babies R Us shops.sourceSponsor:News technical sponsor Sponsor:News AI sponsor Sponsor:

Copyright © 2024 | WordPress Theme: Xews Lite